Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Downregulation of NRF2 by the inhibitor Luteolin , or lentiviral shRNA knockdown, enhanced the chemotherapeutic efficacy of cytarabine , while MDS cells treated by NRF2 agonist Sulforaphane showed increased resistance to cytarabine.”